No benefit of adding axitinib to ocreotide acetate in non-pancreatic neuroendocrine tumours Presented ByDr Rocio Garcia-Carbonero, Hospital Universitario 12 de Octubre, Spain TrialPhase 3, AXINET trial-GETNE-1107 ConferenceASCO GI 2021 12 March, 2021 10:44
